HopeStage
Back to all studies
RecruitingNCT06394284

MDMA-assisted therapy or trauma-focused therapy for veterans with PTSD and moral injury

About this titleRead the official source — NCT06394284
Medication studyIsrael
The study in practice

Understand this study

Listed locations
JerusalemSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 18, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
Herzog Hospital
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
Israel
Age range
Not clearly listed
Official registry ID
NCT06394284
Official title
Show the full official title

IISPT2: Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and MI

Recruitment & locations

Currently recruiting

Jerusalem

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Herzog Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including MDMA-AT.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies